Metraipolis › archive › dc_601239e1867a
Antibody-Drug Conjugates Beyond HER2 in Non-Small Cell Lung Cancer (NSCLC): Mechanisms, Emerging Targets, and Future Directions — Europe PMC PMID:42194027
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42194027
- DOI
- 10.3390/biom16050677
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T21:13:27.166Z
- SHA-256 of the archived text
258d007078c410067e528e3d7ba3d7243e45d8744e8f0060b858ad03dfdee6b3- Stable URL of this page
https://metraipolis.com/documento/dc_601239e1867a
How to cite
Antibody-Drug Conjugates Beyond HER2 in Non-Small Cell Lung Cancer (NSCLC): Mechanisms, Emerging Targets, and Future Directions — Europe PMC PMID:42194027 — Europe PMC (en), https://europepmc.org/article/MED/42194027 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_601239e1867a (Metraipolis archive dc_601239e1867a, sha256 258d007078c410067e528e3d7ba3d7243e45d8744e8f0060b858ad03dfdee6b3)
BibTeX
@misc{dc601239e1867a,
title = {Antibody-Drug Conjugates Beyond HER2 in Non-Small Cell Lung Cancer (NSCLC): Mechanisms, Emerging Targets, and Future Directions — Europe PMC PMID:42194027},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42194027},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_601239e1867a; sha256 258d007078c410067e528e3d7ba3d7243e45d8744e8f0060b858ad03dfdee6b3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42194027. Agents can read the archived copy with the MCP tool read_document.